Compare Hershey Co (HSY) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hershey Co vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Hershey Co trades at $162.12 (market cap $32.66B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.74 (market cap $6.04B). The key difference: Hershey Co is far larger — about 5.4× Iovance Biotherapeutics Inc. Common Stock's market cap, and Hershey Co pays a 3.57% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hershey Co for 135 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| HSY | IOVA | |
|---|---|---|
Market Cap | $32.66B | $6.04B |
Volume | 1,578,237 | 14,805,993 |
Sector | Consumer Staples | Health |
52-Week High | $236.28 | $14.82 |
52-Week Low | $157.61 | $1.81 |
Typical Hold Time | 135 Days | 0 Days |
Enterprise Value | $37.79B | $5.97B |
Dividend Yield | 3.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hershey (HSY) trades at $161.88, up 0.96% with a bearish technical outlook. The stock shows strong profitability with 12.24% net margin and 32.81% ROE, though Q3 2026 earnings are pending. Recent news highlights brand investments and dividend resumption after a near 2-year freeze. Valuation metrics include P/E of 22.2 and P/S of 2.72, with analyst consensus price target at $204.62 representing 26% upside potential.
HSY presents a mixed investment case with strong fundamentals offset by near-term headwinds. The opportunity lies in consistent dividend growth potential and market leadership, while risks include commodity cost pressures and competitive challenges. Analyst sentiment leans cautious with 66% hold ratings, suggesting patience for earnings catalysts and margin stabilization.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hershey Co
Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Read more on HSY →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
